Archives

Major Depressive Disorder In Chronic Kidney Disease
About This Event
Major Depressive Disorder In Chronic Kidney Disease
Major Depressive Disorder affects more than 260 million people worldwide.1 The reported prevalence of depression in patients with Chronic Kidney Disease (CKD) ranges from 20-65%.2 This presentation provides an overview of both MDD and CKD and discusses their overlap of symptomology.
1. World Health Organization. Fact Sheet on Depression. (2012) https://www.who.int/health-topics/depression#tab=tab_1
2. Teles F et al. Clinics (Sao Paulo). 2014 ;69(3):198-202.
Sixty Vines
Featuring

Hannah N. Lambert, PharmD
Hannah N. Lambert is a Medical Science Liaison at Otsuka Pharmaceutical Development and Commercialization. She earned her Doctor of Pharmacy and completed her clinical residency training at Xavier University of Louisiana College of Pharmacy in New Orleans, LA. Prior to joining Otsuka, Dr Lambert was a clinical pharmacist at Ochsner Health in Digital Medicine.

Hasib Bhojwani, MD
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Hasib H. Bhojwani is a Medical Science Liaison for Otsuka Pharmaceuticals Development and Commercialization Inc. His areas of expertise include psychiatric disorders, mood disorders, clinical psychopharmacology, and attention deficit/ hyperactivity disorder. His prior experiences include medical affairs/ clinical research, medical team lead, and neuropsychiatry instructor. He attended medical school at Windsor University School of Medicine.
*Drs Hannah N. Lambert & Hasib Bhojwani are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).